Stocklytics Platform
Asset logo for symbol IDXX
IDEXX Laboratories
IDXX69
$419.26arrow_drop_down2.18%-$9.37
S&P500
Asset logo for symbol IDXX
IDXX69

$419.26

arrow_drop_down2.18%

Income Statement (IDXX)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
EBIT$307.86M$268.53M$304.64M$247.13M$246.29M
EBITDA$341.99M$300.72M$334.55M$276.87M$275.28M
gross Profit$596.03M$620.88M$593.07M$526.16M$547.98M
NET Income$232.84M$203.29M$235.57M$194.52M$212.23M
total Revenue$975.54M$1.00B$964.09M$901.60M$915.52M

Balance Sheet (IDXX)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
cash Equivalents-----
net Debt$689.64M$666.28M$671.50M$493.94M$687.10M
stockholders Equity$1.61B$1.58B$1.56B$1.48B$1.29B
total Assets$3.35B$3.41B$3.35B$3.25B$3.08B
total Debt$998.28M$1.06B$1.06B$947.88M$1.01B
total Liabilities$1.73B$1.83B$1.78B$1.77B$1.78B

Cash Flow (IDXX)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
financing Cash Flow-$290.97M-$210.23M-$144.07M-$101.84M-$43.03M
free Cash Flow$191.99M$215.00M$168.31M$217.29M$238.33M
investing Cash Flow-----
operating Cash Flow$220.07M$248.31M$198.58M$249.85M$272.43M

IDEXX Laboratories (IDXX) Financials

IDEXX Laboratories Inc (IDXX) is a leading provider of diagnostic and technology-based solutions for veterinary, livestock, and poultry markets. The company's income statement reflects its financial performance over a specific period. It shows the revenues generated, expenses incurred, and the resulting net income. By analyzing the income statement, investors can assess the profitability of IDXX. The ebit (earnings before interest and taxes) is a measure of IDXX's operating profitability before taking into account interest and tax expenses. It provides insight into the company's ability to generate profits from its core operations. Similarly, ebitda (earnings before interest, taxes, depreciation, and amortization) measures IDXX's operating profitability without considering depreciation and amortization expenses. Gross profit represents the revenue remaining after subtracting the cost of goods sold. It reveals the profitability of IDXX's products and services before considering other operating expenses. Net income from stockholders represents the profit attributable to the company's shareholders after deducting all expenses and taxes. Total revenue indicates the overall sales generated by IDXX during a specific period. Moving on to the balance sheet, it provides a snapshot of IDXX's financial position at a specific point in time. Cash equivalents refer to highly liquid assets that can be readily converted into cash. Net debt represents the total debt of IDXX minus its cash and cash equivalents. Stockholders' equity represents the residual interest in the company's assets after deducting liabilities. Total assets include all the resources controlled by IDXX, including cash, accounts receivable, inventory, property, and equipment. Total debt comprises all the financial obligations owed by IDXX, including short-term and long-term liabilities. Total liabilities include all the company's obligations to creditors, suppliers, and other external parties. Cash flow represents the movement of cash into or out of IDXX over a specific period. Financing cash flow reflects the company's inflow or outflow of cash from financing activities, such as issuing or repurchasing stocks, paying dividends, or obtaining debt. Free cash flow measures the amount of cash generated by IDXX's operations after subtracting capital expenditures. Investing cash flow represents the cash inflow or outflow from investing activities, such as purchasing or selling assets. Operating cash flow represents the cash generated from IDXX's core operations, excluding financing and investing activities.
add IDEXX Laboratories  to watchlist

Keep an eye on IDEXX Laboratories

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Take Your Investments to a Whole New Level